RT Journal Article
T1 Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study.
A1 Boceta, J
A1 De la Torre, A
A1 Samper, D
A1 Farto, M
A1 Sánchez-de la Rosa, R
K1 Baseline cancer pain
K1 Breakthrough cancer pain
K1 Cancer
K1 Consensus
K1 Delphi
K1 Management
AB There is no unanimous consensus on the clinical features to define breakthrough cancer pain (BTcP). The current project aimed to investigate the opinion of a panel of experts on cancer pain on how to define, diagnose, assess, treat and monitor BTcP. A two-round Spanish multi-centre exploratory Delphi study was conducted with medical experts (n = 90) previously selected from Medical Oncology Services, Radiation Oncology, Palliative Care/Home Care Teams, and Pain Units. The study intended to seek experts' consensus and to define a set of recommendations for the management of BTcP. It was generally agreed that, definition of BTcP implies that baseline pain should be controlled (84 %), although not necessarily with opioids (only 30 %); there must be exacerbations (98.9 %); the duration of each episode should last  The present Delphi study identified a set of recommendations to define, assess and monitor BTcP.
YR 2016
FD 2016
LK http://hdl.handle.net/10668/9818
UL http://hdl.handle.net/10668/9818
LA en
DS RISalud
RD Apr 7, 2025